Muthukumar R: What if One Blood Test Could Tell Doctors Much More Than it Does Today?
Muthukumar R, Founder & CEO of Azaygen India, shared a post on LinkedIn.
“What if one blood test could tell doctors much more than it does today?
That’s the kind of conversation we recently had at the Hematology Department of Christian Medical College (CMC) Vellore Ranipet Campus, while introducing the Randox Evidence MultiStat.
Under the guidance of Dr. Vikram Mathews , the discussion centered on how modern diagnostics are shifting toward seeing the bigger clinical picture especially in understanding Inflammation and immune response.
Instead of running multiple separate tests, the MultiStat can Analyze 9 key biomarkers in a single run. This allows clinicians to understand what’s happening inside the body faster.
And more clearly, whether the concern is infection, clotting complications ,or hematologic disorders.
Markers such as IL-6, TNF-α, Interferon-Gamma, and IL-2 play a critical role in immune regulation and inflammatory pathways.
The ability to obtain insights on these markers in around 60 minutes is especially valuable when managing critically ill patients.
What stood out most was how easily the system fits into real lab workflows compact, efficient, and built for high-volume environments where time truly matters.
More than a technology introduction,it was a meaningful exchange of ideas on where diagnostics is heading. And how precision medicine is becoming increasingly practical.Progress like this happens through collaboration.
And a willingness to rethink how we interpret the body’s signals.”

Stay updated with Hemostasis Today.
-
Feb 5, 2026, 16:20Emmanuel J Favaloro: New Study on Biomarkers for Coagulation Disorders
-
Feb 5, 2026, 16:18Maxime Dely: Trends in Red Blood Cell Consumption in France
-
Feb 5, 2026, 16:17Shervin Jose: How Herbal Medicine Changed World History
-
Feb 5, 2026, 16:12Ahmed Koriesh: Stroke Primary Prevention – Questions We Hear Every Day
-
Feb 5, 2026, 16:10Tsubasa Tsutsumi: Hepatology x Cardiology – A Dialogue on Aspirin and Diet in MASLD
-
Feb 5, 2026, 15:37Abhishek Kumar։ Antiphospholipid Syndrome Therapies – Innovations and Market Outlook to 2034
-
Feb 5, 2026, 15:27Ashu Jadhav: Minocycline in Acute Ischaemic Stroke – Results From the EMPHASIS Trial
-
Feb 5, 2026, 15:19Martin Haluzík: How LPA Variants May Guide Aspirin Therapy in Primary Prevention of Cardiovascular Disease
-
Feb 5, 2026, 14:48Ahmed Abdalbagi: Aspirin vs Plavix – Updated Clinical and Pharmacological Breakdown